Chang L - Search Results

1

Patterns and organ treatment response of Erdheim-Chester disease with cardiac involvement.

Miao HL, Chang L, Lin H, Liu ZZ, Wu W, Niu N, Cao XX. Miao HL, et al. Among authors: chang l. Heart. 2024 Jun 17;110(13):899-907. doi: 10.1136/heartjnl-2024-323867. Heart. 2024. PMID: 38772574 Free PMC article.

2

High Inflammatory Burden: A Potential Cause of Myocardial Injury in Critically Ill Patients With COVID-19.

Song Y, Gao P, Ran T, Qian H, Guo F, Chang L, Wu W, Zhang S. Song Y, et al. Among authors: chang l. Front Cardiovasc Med. 2020 Jul 7;7:128. doi: 10.3389/fcvm.2020.00128. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 32733921 Free PMC article.

3

Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [⁶⁸Ga]pentixafor in non-Hodgkin lymphoma: comparison to [¹⁸F]FDG.

Pan Q, Luo Y, Zhang Y, Chang L, Li J, Cao X, Li J, Li F. Pan Q, et al. Among authors: chang l. EJNMMI Res. 2020 Aug 5;10(1):89. doi: 10.1186/s13550-020-00681-7. EJNMMI Res. 2020. PMID: 32757068 Free PMC article.

4

Myocardial Injury on Admission as a Risk in Critically Ill COVID-19 Patients: A Retrospective in-ICU Study.

Qian H, Gao P, Tian R, Yang X, Guo F, Li T, Liu Z, Wang J, Zhou X, Qin Y, Chang L, Song Y, Yan X, Wu W, Zhang S. Qian H, et al. Among authors: chang l. J Cardiothorac Vasc Anesth. 2021 Mar;35(3):846-853. doi: 10.1053/j.jvca.2020.10.019. Epub 2020 Oct 16. J Cardiothorac Vasc Anesth. 2021. PMID: 33162306 Free PMC article.

5

Risk of hepatitis B virus reactivation following ruxolitinib treatment in patients with myeloproliferative neoplasms.

Duan MH, Cao XX, Chang L, Zhou DB. Duan MH, et al. Among authors: chang l. Hematology. 2021 Dec;26(1):460-464. doi: 10.1080/16078454.2021.1945234. Hematology. 2021. PMID: 34184610 Free article.

6

Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study.

Mao YY, Cai HC, Shen KN, Chang L, Zhang L, Zhang Y, Feng J, Wang W, Yang C, Zhu TN, Duan MH, Zhou DB, Cao XX, Li J. Mao YY, et al. Among authors: chang l. Ann Hematol. 2022 Apr;101(4):831-836. doi: 10.1007/s00277-022-04764-4. Epub 2022 Jan 17. Ann Hematol. 2022. PMID: 35039900 Clinical Trial.

7

Prevalence, clinical characteristics and treatment outcome of factor X deficiency in a consecutive cohort of primary light-chain amyloidosis.

Gao YJ, Shen KN, Chang L, Feng J, Mao YY, Zhang L, Cao XX, Zhou DB, Li J. Gao YJ, et al. Among authors: chang l. Leuk Res. 2022 Sep;120:106917. doi: 10.1016/j.leukres.2022.106917. Epub 2022 Jul 5. Leuk Res. 2022. PMID: 35849875

8

Case Report: TEMPI syndrome: Report of three cases and treatment follow-up.

Xu ZF, Ruan J, Chang L, Wu S, Lin J, Wang W, Cao X, Zhang L, Li J, Zhou D, Zhang W. Xu ZF, et al. Among authors: chang l. Front Oncol. 2022 Aug 3;12:949647. doi: 10.3389/fonc.2022.949647. eCollection 2022. Front Oncol. 2022. PMID: 35992844 Free PMC article.

9

Corrigendum to "Prevalence, clinical characteristics and treatment outcome of factor X deficiency in a consecutive cohort of primary light-chain amyloidosis" Leuk. Res. 120C (2022) 106917.

Gao YJ, Shen KN, Chang L, Feng J, Mao YY, Zhang L, Cao XX, Zhou DB, Li J. Gao YJ, et al. Among authors: chang l. Leuk Res. 2023 Jan;124:107003. doi: 10.1016/j.leukres.2022.107003. Epub 2022 Dec 23. Leuk Res. 2023. PMID: 36567140 No abstract available.

10

Gamma heavy chain disease: a retrospective analysis of 6 cases.

Chang L, Zhou DB, Cao XX. Chang L, et al. Orphanet J Rare Dis. 2023 Apr 11;18(1):77. doi: 10.1186/s13023-023-02679-5. Orphanet J Rare Dis. 2023. PMID: 37041608 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,569 results

Search Page

Filters